These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15947536)

  • 1. New graduated pressure regimen for external counterpulsation reduces mortality and improves outcomes in congestive heart failure: a report from the Cardiomedics External Counterpulsation Patient Registry.
    Vijayaraghavan K; Santora L; Kahn J; Abbott N; Torelli J; Vardi G
    Congest Heart Fail; 2005; 11(3):147-52. PubMed ID: 15947536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR).
    Soran O; Kennard ED; Kelsey SF; Holubkov R; Strobeck J; Feldman AM
    Congest Heart Fail; 2002; 8(6):297-302. PubMed ID: 12461318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel possibilities in the treatment of patients with heart failure. The method of external counterpulsation].
    Gabrusenko SA; Malakhov VV; Sergienko IV; Bugriĭ ME; Saidova MA; Kukharchuk VV; Belenkov IuN
    Kardiologiia; 2008; 48(9):10-6. PubMed ID: 18991815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation.
    Lawson WE; Silver MA; Hui JC; Kennard ED; Kelsey SF
    J Card Fail; 2005 Feb; 11(1):61-6. PubMed ID: 15704066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis.
    McKenna C; McDaid C; Suekarran S; Hawkins N; Claxton K; Light K; Chester M; Cleland J; Woolacott N; Sculpher M
    Health Technol Assess; 2009 Apr; 13(24):iii-iv, ix-xi, 1-90. PubMed ID: 19409154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.
    Stellbrink C; Auricchio A; Diem B; Breithardt OA; Kloss M; Schöndube FA; Klein H; Messmer BJ; Hanrath P
    Am J Cardiol; 1999 Mar; 83(5B):143D-150D. PubMed ID: 10089857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graduated pressure regimen for external counterpulsation (ECP) for patients with heart failure.
    Michaels AD; Soran O
    Congest Heart Fail; 2005; 11(5):278; author reply 279-80. PubMed ID: 16312057
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).
    Soran O; Kennard ED; Kfoury AG; Kelsey SF;
    Am J Cardiol; 2006 Jan; 97(1):17-20. PubMed ID: 16377276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris.
    Shechter M; Matetzky S; Feinberg MS; Chouraqui P; Rotstein Z; Hod H
    J Am Coll Cardiol; 2003 Dec; 42(12):2090-5. PubMed ID: 14680732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure.
    Kadoglou NP; Mandila C; Karavidas A; Farmakis D; Matzaraki V; Varounis C; Arapi S; Perpinia A; Parissis J
    Eur J Prev Cardiol; 2017 May; 24(8):833-839. PubMed ID: 28079427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
    Krahn AD; Snell L; Yee R; Finan J; Skanes AC; Klein GJ
    Can J Cardiol; 2002 Apr; 18(4):380-7. PubMed ID: 11992131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the International EECP Patient Registry (IEPR).
    Michaels AD; Kennard ED; Kelsey SE; Holubkov R; Soran O; Spence S; Chou TM
    Clin Cardiol; 2001 Jun; 24(6):453-8. PubMed ID: 11403506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
    Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following surgical ventricular restoration for patients with clinically advanced congestive heart failure (New York Heart Association Class IV).
    Williams JA; Weiss ES; Patel ND; Nwakanma LU; Conte JV
    J Card Fail; 2007 Aug; 13(6):431-6. PubMed ID: 17675056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris.
    Holubkov R; Kennard ED; Foris JM; Kelsey SF; Soran O; Williams DO; Holmes DR
    Am J Cardiol; 2002 May; 89(10):1182-6. PubMed ID: 12008172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.